Announced Sat, 30 May · 18:14 IST

Audited Standalone and Consolidated Financial results for the FY 2025-26.

Pat Growth 25pctNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹12.96
prior close
₹13.15
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-1.2-1.2-1.2-0.5+1.8-2.2-3.5-5.2-2.2-2.0-3.5
Up moveDown movePending
AI summary

Deccan Health Care Ltd reported standalone revenue of Rs 8,917.10 lakhs for FY26, up 18.7% from Rs 7,513.19 lakhs in FY25. Net Profit After Tax grew significantly to Rs 229.04 lakhs from Rs 119.79 lakhs, representing a 91% increase. Consolidated financials show revenue of Rs 8,190.48 lakhs and PAT of Rs 248.76 lakhs (including subsidiary Beyoungstore). The statutory auditor Keyur Shah & Associates issued an Unmodified (clean) opinion on both standalone and consolidated results. However, operating cash flows remain negative at Rs 358.75 lakhs (standalone) and Rs 362.13 lakhs (consolidated), indicating cash burn despite profitability. The company also reported forfeiture of Rs 75 lakhs worth of share warrants due to non-exercise within the 18-month period.

Likely market impact

Strong PAT growth signals operational efficiency, but negative operating cash flows raise concerns about liquidity and cash conversion. Investors should monitor working capital management.